Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells

Cell Death and Differentiation

Volumn 5, Issue 5, 1998, Pages 450-457

  Tillman, David M ^a   Harwood, Franklin G ^a   Gibson, Alice A ^a   Houghton, Janet A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Apoptosis; Colon carcinoma cells; Fas signalling; Gene expression

Indexed keywords

FAS ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

EID: 0031870398     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400369     Document Type: Article

References (34)

1. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR and Jones RJ (1995) Inhibition of apoptosis during development of colorectal cancer Cancer Res. 55: 1811-1816
2. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH and Wallach D (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798
3. Boldin MP, Goncharov TM, Goltsev YV and Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85: 803-815
4. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ and Mountz JD (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762
5. Chinnaiyan AM, O'Rourke K, Tewari M and Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512
6. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Lou L, Kischkel FC, Hellbardt S, Krammer PH, Peter ME and Dixit VM (1996) FADD/MORT1 ia a common mediator of Fas/APO-1- and tumor necrosis factor-induced apoptosis. J. Biol. Chem 271: 4961-4965
7. Fearon ER and Vogelstein BA (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
8. French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker, K , Muller C and Tschopp J (1996) Fas and Fas ligand in embryos and adult mice. ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133: 335-343
9. Harwood FG, Frazier MW, Krajewski S, Reed JC, Houghton JA (1996) Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells. Oncogene 12: 2057-2067
10. Houghton JA, Adkins DA, Rahman A and Houghton PJ (1991) Interaction between 5-fluorouracil, [6RS]leucovorin, and recombinant human interferon-α2a in cultured colon adenocarcinoma cells. Cancer Commun. 3: 225-231
11. Houghton JA, Harwood FG and Tillman DM (1997a) Thymineless death in colon carcinoma cells is mediated via Fas signalling. Proc. Natl. Acad. Sci USA 94: 8144-8149
12. Houghton JA, Harwood FG, Gibson AA and Tillman DM (1997b) The Fas signalling pathway is functional in colon carcinoma cells and induces apoptosis. Clin Cancer Res., in press
13. Houghton JA, Tillman DM and Harwood FG. (1995) Ratio of 2′-deoxyadenosine-5′-triphosphate/thymidine-5′-triphosphate influences the commitment of human colon carcinoma cells to thymineless death Clin. Cancer Res. 1: 723-730
14. Hu S, Vincenz C, Ni J, Gentz R and Dixit VM (1997) I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95-induced apoptosis. J Biol. Chem 272: 17255-17257
15. Itoh N and Nagata S (1993) A novel protein domain required for apoptosis J. Biol. Chem 268: 10932-10937
16. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y and Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243
17. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Bruderlein S, Henne C, Schmidt A, Debatin K-M, Krammer PH and Moller P (1993) Constitutive and induced expression of APO-1 a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells Lab Invest. 69: 415-429
18. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer P and Peter M (1997) FLICE is activated by associatioin with the CD95 death-inducing signaling complex (DISC). EMBO J. 16: 2794-2804
19. Meterissian S and Kontogiannea M (1996) Fas antigen expression and function in human colorectal carcinoma. Correlation with Bcl-2 expression. Proc Am Assoc. Cancer Res 37: 15
20. Midis GP, Shen Y and Owen-Schaub LB (1996) Elevated soluble Fas (sFas) levels in nonhematopoietic human malignany. Cancer Res. 56: 3870-3874
21. Moller P, Koretz K, Leithauser F, Bruderlein S, Henne C, Quentmeier A and Krammer P (1994) Expression of Apo-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J Cancer 57: 371-377
22. Mon S, Murakami-Mori K, Jenett A, Nakamura S and Bonavida B (1996) Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Cancer Res. 56: 1874-1879
23. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827
24. O'Connell J, O'Sullivan GC, Collins JK and Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184: 1075-1082
25. Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD, GilbertJR, Shekhtman EM, Tomei D, Umansky SR and Kiefer MC (1997) Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272: 16351-16357
26. Peter ME, Kischkel FC, Hellbardt S, Chinnaiyan AM, Krammer PH and Dixit VM (1996) CD95)APO-1/Fas)- associating signalling proteins. Cell Death Differ 3: 161-170
27. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A and de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349
28. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA and Cohen MB (1997) Fas-mediated apoptosis in prostatic carcinoma cell lines. Cancer Res. 57: 1758-1768
29. Sato T, Irie S, Kitada S and Reed JC (1995) FAP-1 A protein tyrosine phosphatase that associates with Fas. Science 268: 411-415
30. Suda T, Takahashi T, Golstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand. a novel member of the TNF family. Cell 75: 1169-1178
31. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin K-M and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305
32. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA and Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
33. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y and Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. J. Clin. Invest 94: 954-964
34. Yanagisawa J, Takahashi M, Kanki H, Yanagisawa HY, Tazunoki T, Sawa E, Nishitoba T, Kamishohara M, Kobayashi S and Sato T (1997) The molecular interaction of Fas and FAP-1. J. Biol. Chem. 272: 8539-8545